
Oncology NEWS International
- Oncology NEWS International Vol 5 No 7
 - Volume 5
 - Issue 7
 
NIH Plans to Disband RAC
Bethesda , Md--NIH director Harold Varmus has announced plants to disband the Recombinant DNA Advisory Committee (RAC). The committee was formed in 1975 as a panel of 24 scientists, ethicists, and others at NIH dedicated to holding those in the field of biogenetics accountable to the public.
Bethesda , Md--NIH director Harold Varmus has announced plantsto disband the Recombinant DNA Advisory Committee (RAC). The committeewas formed in 1975 as a panel of 24 scientists, ethicists, andothers at NIH dedicated to holding those in the field of biogeneticsaccountable to the public.
The RAC created the first safety guidelines for genetically engineeringmicrobes, instituted a formal review system for studies involvinginsertion of new genes into humans, and, in 1990, gave the firstapproval of a human gene therapy experiment. RAC approval wasrequired before the FDA would consider any gene therapy proposal.
Now, Dr. Varmus believes the RAC is no longer necessary, as theFDA can handle all new proposals with the help of ad hoc committeesconvened as needed.
Articles in this issue
over 29 years ago
Princess Diana Helps Raise Over $1 Million for Cancer Researchover 29 years ago
Study Gives Terminal Patients Option: $18,000 or More Treatmentover 29 years ago
Proven: Colorectal Screening Cuts Deaths 50%over 29 years ago
Virtual Colonoscopy Technique Feasible in Detecting Polypsover 29 years ago
Trimetrexate Appears Beneficial in Colorectal Cancerover 29 years ago
FDA Liaison Program Answers Patients' Questions About Trialsover 29 years ago
New Company Joins With RPR To Develop Intrabody Technologyover 29 years ago
More Insurers Covering ABMT, Despite Lack of Efficacy Dataover 29 years ago
CDC Says Teen Smoking Still RisingNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.



















































































